SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
基本信息
- 批准号:6778026
- 负责人:
- 金额:$ 7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-16 至 2004-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Abstract) The purpose of this proposed research
program is to develop new general methods for the construction of several
biologically active polypropionate natural products. The key step in the
syntheses of these compounds involves a concerted Lewis acid-promoted
rearrangement of an optically active epoxy alcohol to generate a
2-methyl-3-trialkylsilyloxyalkanal, namely an aldol product by a non-aldol
route. We have shown that all four possible enantiomers can be easily prepared
in high optical purity and good yields by this approach. We plan to extend this
research to prepare polypropionate chains with various absolute
stereochemistries. In particular, in order to illustrate the efficiency of this
process, we will finish the synthesis of two extremely strongly cytotoxic
agents, 13-deoxytedanolide 1 and tedanolide 2, and their close structural
analogues, by an application of this new approach to polypropionates.
13-Deoxytedanolide is extremely cytotoxic (IC50 94 pg/ml (P388)) and has high
antitumor activity (T/C 189 percent (P388) at 125 microg/kg) while tedanolide
is also extremely tumor inhibitory (ED50's 250 pg/ml (KB) and 16 pg/ml (PS))
and causes accumulation of cells in the S phase at very low concentrations (10
ng/ml). Thus they are very promising leads as new agents for cancer treatment.
The development of good general routes for their synthesis would not only
provide a potentially useful preparation of them (both were isolated from
marine sponges and are present in very small quantities) but also would allow
one to prepare several structural analogues unavailable from natural sources
which may show enhanced chemotherapeutic properties. We will also carry out
total syntheses of the important antibacterial agents, erythromycin A 3 and
oleandomycin 4. All of the advanced synthetic materials in the tedanolide
series will be tested for antitumor activity. In this way, we hope to figure
out just what parts of these complex molecules are required for the potent
activity and hopefully to prepare some simpler structures which still show
reasonable activity. Likewise the synthetic analogues of erythromycin and
oleandomycin will be tested for antibiotic activity. The successful
accomplishment of the research described in this proposal-namely, the
development of a really useful synthetic route to polypropionates and the
synthesis of the tedanolides, erythromycin A and oleandomycin and their
analogues-would be of great significance to medicinal chemistry. Because of the
medicinal importance of the targets, the efficiency of bond construction in the
syntheses, and the high intrinsic value of the new methods themselves, the
likelihood of an important contribution to health-related science is quite
high.
描述:(申请人摘要)这项拟议研究的目的
方案是制定新的通用施工方法的几个
具有生物活性的聚丙酸酯天然产物。关键的一步是
这些化合物的合成涉及路易斯酸促进的协同作用
光学活性环氧醇的重排以生成
2-甲基-3-三烷基硅氧烷,即由非羟醛生成的羟醛产物
路线。我们已经证明,所有四种可能的对映体都可以很容易地制备出来
该方法具有光学纯度高、产率高等优点。我们计划延长这一期限
制备不同绝对数聚丙酸链的研究
立体化学。特别是,为了说明这一点的效率
过程中,我们将完成两个极强的细胞毒性的合成
13-脱氧萜内酯1和萜内酯2及其紧密结构
类似物,通过将这一新方法应用于聚丙酸酯。
13-脱氧戊二内酯具有极强的细胞毒性(IC50为94 pg/ml(P388)),并具有很高的
抗肿瘤活性(T/C 189%(P388),125微克/公斤)
对肿瘤也有极强的抑制作用(ED50‘S 250pg/ml(KB)和16pg/ml(PS))
并在极低浓度(10%)下导致S期细胞积累
Ng/ml)。因此,它们作为癌症治疗的新药物是非常有希望的线索。
为它们的合成开发良好的一般路线不仅将
提供可能有用的它们的制剂(两者都是从
海绵和数量非常少的海绵),但也允许
一是制备几种天然来源无法获得的结构类似物
这可能显示出增强的化疗特性。我们还将开展
重要抗菌药红霉素A_3和红霉素的全合成
齐墩果霉素4.所有先进的合成材料在替丹内酯
将对该系列药物进行抗肿瘤活性测试。通过这种方式,我们希望能够计算出
弄清楚这些复杂分子的哪些部分是有效的
活动,并希望准备一些更简单的结构,仍然显示
合理的活动。同样,红霉素和红霉素的合成类似物
奥兰霉素将接受抗生素活性测试。成功者
完成本建议中所述的研究--即
开发一种真正有用的合成聚丙酸酯的路线和
萜类内酯、红霉素A和油兰霉素的合成及其性能
类似物-将对药物化学具有重要意义。因为
靶标的药用价值,键构筑的效率
综合,以及新方法本身的高内在价值,
对健康相关科学做出重要贡献的可能性是相当大的
很高。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A tandem non-aldol aldol Mukaiyama aldol reaction.
串联非羟醛羟醛向山羟醛反应。
- DOI:10.1021/ol0358760
- 发表时间:2003
- 期刊:
- 影响因子:5.2
- 作者:Jung,MichaelE;vandenHeuvel,Alexandra
- 通讯作者:vandenHeuvel,Alexandra
Efficient synthesis of the C(1)-C(11) fragment of the tedanolides. The nonaldol aldol process in synthesis.
高效合成 tedanolides 的 C(1)-C(11) 片段。
- DOI:10.1021/ol005675l
- 发表时间:2000
- 期刊:
- 影响因子:5.2
- 作者:Jung,ME;Marquez,R
- 通讯作者:Marquez,R
Synthesis of a fully functionalized protected C1-C11 fragment for the synthesis of the tedanolides.
合成全功能化的受保护 C1-C11 片段,用于合成 tedanolides。
- DOI:10.1021/ol000329p
- 发表时间:2001
- 期刊:
- 影响因子:5.2
- 作者:Jung,ME;Lee,CP
- 通讯作者:Lee,CP
Synthesis of four diastereomeric 3,5-dialkoxy-2,4-dimethylalkanals by a simple extension of the non-aldol aldol process to bis(propionates).
通过将非羟醛羟醛过程简单延伸至双(丙酸酯)合成四种非对映异构体 3,5-二烷氧基-2,4-二甲基烷醛。
- DOI:10.1021/ol990619
- 发表时间:1999
- 期刊:
- 影响因子:5.2
- 作者:Jung,ME;Lee,WS;Sun,D
- 通讯作者:Sun,D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E JUNG其他文献
MICHAEL E JUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E JUNG', 18)}}的其他基金
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2010749 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2608152 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6592046 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6624727 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6475903 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6328962 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2837715 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
2904802 - 财政年份:1996
- 资助金额:
$ 7万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 7万 - 项目类别:
Engage Grants Program
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 7万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 7万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 7万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 7万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 7万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 7万 - 项目类别:














{{item.name}}会员




